# NexPoint Residential Trust, Inc.: financial statements, quarterly

NXRT · NYSE · CIK 1620393 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nxrt.md) · [Financials](/companies/nxrt/financials.md) · [Filings](/companies/nxrt/filings.md) · [Insiders](/companies/nxrt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nxrt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [69.8](/filings/0000950170-24-118609.md) | [68.9 d](/filings/0001193125-26-077343.md) | [67.6](/filings/0000950170-25-062150.md) | [64.2](/filings/0000950170-25-100309.md) | [64.1](/filings/0001193125-25-254873.md) | [63.8 d](/filings/0001193125-26-077343.md) | [63.2](/filings/0001193125-26-192096.md) | [63.1](/filings/0001193125-26-333942.md) | [62.8](/filings/0001193125-25-254873.md) | [62.1 d](/filings/0001193125-26-077343.md) | [63.5](/filings/0001193125-26-192096.md) | [64.6](/filings/0001193125-26-333942.md) |
| Operating income | $m | [53.5](/filings/0000950170-24-118609.md) | [36.6 d](/filings/0001193125-26-077343.md) | [41.0](/filings/0000950170-25-062150.md) | [25.5](/filings/0000950170-25-100309.md) | [5.6](/filings/0001193125-25-254873.md) | [11.5 d](/filings/0001193125-26-077343.md) | [7.4](/filings/0001193125-26-192096.md) | [7.9](/filings/0001193125-26-333942.md) | [7.4](/filings/0001193125-25-254873.md) | [5.2 d](/filings/0001193125-26-077343.md) | [8.5](/filings/0001193125-26-192096.md) | [7.1](/filings/0001193125-26-333942.md) |
| Interest expense | $m | [17.6](/filings/0000950170-24-118609.md) | [18.3 d](/filings/0001193125-26-077343.md) | [14.4](/filings/0000950170-25-062150.md) | [14.0](/filings/0000950170-25-100309.md) | [14.6](/filings/0001193125-25-254873.md) | [15.5 d](/filings/0001193125-26-077343.md) | [14.4](/filings/0001193125-26-192096.md) | [15.2](/filings/0001193125-26-333942.md) | [15.5](/filings/0001193125-25-254873.md) | [15.7 d](/filings/0001193125-26-077343.md) | [15.4](/filings/0001193125-26-192096.md) | [15.8](/filings/0001193125-26-333942.md) |
| Net income | $m | [33.7](/filings/0000950170-24-118609.md) | [18.4 d](/filings/0001193125-26-077343.md) | [26.3](/filings/0000950170-25-062150.md) | [10.6](/filings/0000950170-25-100309.md) | [(8.9)](/filings/0001193125-25-254873.md) | [(26.9) d](/filings/0001193125-26-077343.md) | [(6.9)](/filings/0001193125-26-192096.md) | [(7.0)](/filings/0001193125-26-333942.md) | [(7.8)](/filings/0001193125-25-254873.md) | [(10.3) d](/filings/0001193125-26-077343.md) | [(6.8)](/filings/0001193125-26-192096.md) | [(8.6)](/filings/0001193125-26-333942.md) |
| Diluted EPS | $ per share | [1.28](/filings/0000950170-24-118609.md) | not reported | [1.00](/filings/0000950170-25-062150.md) | [0.40](/filings/0000950170-25-100309.md) | [(0.35)](/filings/0001193125-25-254873.md) | not reported | [(0.27)](/filings/0001193125-26-192096.md) | [(0.28)](/filings/0001193125-26-333942.md) | [(0.31)](/filings/0001193125-25-254873.md) | not reported | [(0.27)](/filings/0001193125-26-192096.md) | [(0.34)](/filings/0001193125-26-333942.md) |
| Basic EPS | $ per share | [1.31](/filings/0000950170-24-118609.md) | not reported | [1.02](/filings/0000950170-25-062150.md) | [0.41](/filings/0000950170-25-100309.md) | [(0.35)](/filings/0001193125-25-254873.md) | not reported | [(0.27)](/filings/0001193125-26-192096.md) | [(0.28)](/filings/0001193125-26-333942.md) | [(0.31)](/filings/0001193125-25-254873.md) | not reported | [(0.27)](/filings/0001193125-26-192096.md) | [(0.34)](/filings/0001193125-26-333942.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.5](/filings/0000950170-23-062085.md) | [12.4](/filings/0000950170-25-027741.md) | [37.2](/filings/0000950170-24-052406.md) | [21.3](/filings/0000950170-24-088942.md) | [17.4](/filings/0000950170-24-118609.md) | [23.1](/filings/0001193125-26-077343.md) | [23.7](/filings/0000950170-25-062150.md) | [13.6](/filings/0000950170-25-100309.md) | [10.8](/filings/0001193125-25-254873.md) | [13.7](/filings/0001193125-26-333942.md) | [18.5](/filings/0001193125-26-192096.md) | [14.6](/filings/0001193125-26-333942.md) |
| Total assets | $m | [2,180](/filings/0000950170-23-062085.md) | [2,108](/filings/0000950170-25-027741.md) | [2,043](/filings/0000950170-24-052406.md) | [1,989](/filings/0000950170-24-088942.md) | [1,953](/filings/0000950170-24-118609.md) | [1,907](/filings/0001193125-26-077343.md) | [1,882](/filings/0000950170-25-062150.md) | [1,857](/filings/0000950170-25-100309.md) | [1,842](/filings/0001193125-25-254873.md) | [1,886](/filings/0001193125-26-333942.md) | [1,873](/filings/0001193125-26-192096.md) | [1,878](/filings/0001193125-26-333942.md) |
| Total liabilities | $m | [1,661](/filings/0000950170-23-062085.md) | [1,608](/filings/0000950170-25-027741.md) | [1,525](/filings/0000950170-24-052406.md) | [1,492](/filings/0000950170-24-088942.md) | [1,500](/filings/0000950170-24-118609.md) | [1,491](/filings/0001193125-26-077343.md) | [1,496](/filings/0000950170-25-062150.md) | [1,504](/filings/0000950170-25-100309.md) | [1,514](/filings/0001193125-25-254873.md) | [1,586](/filings/0001193125-26-333942.md) | [1,595](/filings/0001193125-26-192096.md) | [1,626](/filings/0001193125-26-333942.md) |
| Long-term debt | $m | [1,616](/filings/0000950170-23-062085.md) | [1,575](/filings/0000950170-24-021143.md) | [1,498](/filings/0000950170-24-052406.md) | not reported | not reported | not reported | not reported | not reported | not reported | [1,593](/filings/0001193125-26-077343.md) | [1,601](/filings/0001193125-26-192096.md) | [1,623](/filings/0001193125-26-333942.md) |
| Shareholders' equity | $m | [514](/filings/0000950170-23-062085.md) | [495](/filings/0000950170-25-027741.md) | [513](/filings/0000950170-24-052406.md) | [491](/filings/0000950170-24-088942.md) | [447](/filings/0000950170-24-118609.md) | [410](/filings/0001193125-26-077343.md) | [380](/filings/0000950170-25-062150.md) | [348](/filings/0000950170-25-100309.md) | [323](/filings/0001193125-25-254873.md) | [295](/filings/0001193125-26-333942.md) | [272](/filings/0001193125-26-192096.md) | [248](/filings/0001193125-26-333942.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [27.8 d](/filings/0000950170-24-118609.md) | [14.8 d](/filings/0001193125-26-077343.md) | [19.7](/filings/0000950170-25-062150.md) | [19.7 d](/filings/0000950170-25-100309.md) | [27.8 d](/filings/0001193125-25-254873.md) | [6.4 d](/filings/0001193125-26-077343.md) | [28.3](/filings/0001193125-26-192096.md) | [19.9 d](/filings/0001193125-26-333942.md) | [29.3 d](/filings/0001193125-25-254873.md) | [6.1 d](/filings/0001193125-26-077343.md) | [23.3](/filings/0001193125-26-192096.md) | [24.4 d](/filings/0001193125-26-333942.md) |
| Dividends paid | $m | [10.8 d](/filings/0000950170-24-118609.md) | [11.9 d](/filings/0001193125-26-077343.md) | [12.7](/filings/0000950170-25-062150.md) | [11.9 d](/filings/0000950170-25-100309.md) | [11.7 d](/filings/0001193125-25-254873.md) | [13.0 d](/filings/0001193125-26-077343.md) | [14.0](/filings/0001193125-26-192096.md) | [13.1 d](/filings/0001193125-26-333942.md) | [12.9 d](/filings/0001193125-25-254873.md) | [13.4 d](/filings/0001193125-26-077343.md) | [14.5](/filings/0001193125-26-192096.md) | [13.7 d](/filings/0001193125-26-333942.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-25-254873.md) | [0.0 d](/filings/0001193125-26-077343.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-254873.md) | [0.0 d](/filings/0001193125-26-077343.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.6](/filings/0000950170-23-062085.md) | [25.6](/filings/0000950170-24-052406.md) | [25.7](/filings/0000950170-24-088942.md) | [26.3](/filings/0000950170-24-118609.md) | [26.4](/filings/0000950170-25-062150.md) | [26.3](/filings/0000950170-25-100309.md) | [25.4](/filings/0001193125-25-254873.md) | [25.4](/filings/0001193125-26-192096.md) | [25.4](/filings/0001193125-26-333942.md) | [25.4](/filings/0001193125-25-254873.md) | [25.4](/filings/0001193125-26-192096.md) | [25.5](/filings/0001193125-26-333942.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,549,813 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-333942.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.